Sign up to save your podcasts
Or
Share What’s the Consensus on Cardiorenal Protection for CKD in T2D?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
CME credits: 0.50
Valid until: 13-07-2024
Claim your CME credit at https://reachmd.com/programs/cme/whats-the-consensus-on-cardiorenal-protection-for-ckd-in-t2d/14595/
Managing chronic kidney disease (CKD) and type 2 diabetes (T2D) with multiple medications has become a challenge, and a multidisciplinary approach is needed to achieve optimal cardiorenal outcomes. Join Drs. George Bakris, Mikhail Kosiborod, and Tessa Laubscher as they discuss initiating consensus-based nonsteroidal MRA therapy in their patients with CKD and T2D.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 13-07-2024
Claim your CME credit at https://reachmd.com/programs/cme/whats-the-consensus-on-cardiorenal-protection-for-ckd-in-t2d/14595/
Managing chronic kidney disease (CKD) and type 2 diabetes (T2D) with multiple medications has become a challenge, and a multidisciplinary approach is needed to achieve optimal cardiorenal outcomes. Join Drs. George Bakris, Mikhail Kosiborod, and Tessa Laubscher as they discuss initiating consensus-based nonsteroidal MRA therapy in their patients with CKD and T2D.
=